News

The pre-clinical study compared the use of aerosolised IFN-beta against placebo as either a pre-infection protective measure or as a post-infection treatment measure. The study also reported that

According to the company, the new center, , which is worth CHF250m ($271m), will take the responsibility for investigation and development of pharmaceutical formulations for new active ingredients,

The new system will be used effectively from mid-January 2012 by all the MR and MA of Chugai. A wide range of information is provided to medical professionals,

Sagnieres’ chairman and CEO position will be effective from 2 January 2012. Since 1 January 2010, Hubert Sagnieres has served at Essilor as CEO and chief operating officer

The Drugs of Abuse Array V (DoA V) will enable detection of eight designer drugs and their metabolites within a single undivided specimen. The panel targets Methcathinone, Mephedrone,

Under the acquisition, Bellwyck’s Healthcare Division operates Ontario – based Ace which provides solid dose primary and secondary packaging to over the counter (OTC) and prescription pharmaceuticals. Pharmaceuticals

LSDs which are inherited metabolic disorders can be treated with an enzyme replacement therapy (ERT). biOasis and Shire’s scientists will jointly collaborate to evaluate the potential of Transcend

According to the company, the transaction is expected to close in a span of five or six months. Transgene Biotek managing director KK Rao said the deal would

SYN118 is a potent and selective inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), which is an enzyme in the primary pathway responsible for the breakdown of tyrosine, the precursor of